This UK study highlights the urgent need for targeted interventions and close monitoring to improve the quality of life for hemophilia patients suffering from ankle arthropathy.

Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.

Discover how mechanoresilient cancer cells evade the body’s natural defenses and what this means for the future of targeted cancer therapies.

The FDA approval of motixafortide in combination with filgrastim offers a new, evidence-based approach to improve stem cell mobilization in multiple myeloma patients undergoing ASCT.

The recent study on vemurafenib and obinutuzumab offers a promising treatment pathway for previously untreated HCL patients, achieving high rates of complete remission and minimal residual disease negativity.

New research indicates that PCI offers significant survival advantages over TRT in treating extensive-stage small cell lung cancer, challenging existing treatment protocols.